Table 1 HPV status at baseline and incidence of CIN3+ in the different age groups during 30 years of follow-up
Age (years) | Total | HPV positive at baseline (95% CI) | Histological confirmed CIN3+ (95% CI) |
|---|---|---|---|
16–24 | 193 | 89 (46.1%, 39.0–53.4) | 36 (18.7%, 13.6–25.0) |
25–33 | 192 | 75 (39.1%, 32.2–46.4) | 69 (35.9%, 29.2–43.2) |
34–69 | 250 | 58 (23.2%, 18.2–29.0) | 43 (17.2%, 12.9–22.6) |
> 70 | 7 | 1 | 0 (0.0%) |
Total | 642 | 223 (34.7%, 31.1–38.6) | 148 (23.1%, 19.9–26.5) |